Certificate of Analysis Policy
Placeholder — not reviewed by counsel
This document is a structural scaffold, not legal advice, and has not been reviewed. The headings reflect what this policy conventionally covers so counsel has a shape to work against. It must be drafted and approved before launch. This page is excluded from search indexing while in this state.
Editable at src/lib/data/legal.ts
This policy describes what a King Biologix Certificate of Analysis represents, and what it does not. This document is a structural placeholder pending review by counsel and confirmation of the analytical workflow.
1. Scope of a Certificate
A Certificate of Analysis describes findings for a single identified lot as of the stated date of analysis. It is not a representation about other lots, future production, or the suitability of the material for any particular method.
2. Methods
PLACEHOLDER — Describe only the analytical methods actually performed, and identify who performs them. Do not claim third-party testing, accredited laboratories, or specific standards unless documentation supports the claim.
3. Document Availability
PLACEHOLDER — State when documents are issued, how they are accessed, and the expected turnaround where a record is pending.
4. Superseded Documents
Where a record is superseded, the prior document is marked as such rather than removed, so that a researcher holding the earlier version can identify its status.
5. Authenticity
PLACEHOLDER — Describe the authenticity-verification mechanism. Buyers should be able to confirm that a document presented to them originated from King Biologix. See the fraud-prevention guidance on the COA Lookup page.
6. Limitations
PLACEHOLDER — Counsel to draft. Should state clearly that a Certificate of Analysis is not a guarantee of purity, not a warranty of fitness, and not a regulatory clearance.